Patents by Inventor Aijun Sun

Aijun Sun has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11779575
    Abstract: The use of a Wnt inhibitor Wnt-C59 in the preparation of a drug for treating SCN5A mutation-induced dilated cardiomyopathy (DCM) is provided. With SCN5A genotype detection as a breakthrough point, a Wnt pathway-specific inhibitor Wnt-C59 is used to inhibit the abnormal activation of the Wnt?-Catenin pathway caused by SCN5A gene mutation, thereby improving the prognosis of cardiac function in a patient with SCN5A gene mutation-induced DCM. In experiments, aging and adriamycin-induced DCM models are constructed, and the therapeutic effect of Wnt-C59 on DCM is detected through indexes such as changes in cardiac function and activation of related signal molecules, which provides a theoretical basis for use of Wnt-C59 in the clinical treatment of DCM. A new treatment method for SCN5A mutation-induced DCM is provided to bring dawn to such patients and has promising application prospects.
    Type: Grant
    Filed: August 6, 2021
    Date of Patent: October 10, 2023
    Assignee: ZHONGSHAN HOSPITAL, FUDAN UNIVERSITY
    Inventors: Junbo Ge, Aijun Sun, Jingjing Hu, Kun Yang
  • Publication number: 20220370428
    Abstract: The use of a Wnt inhibitor Wnt-C59 in the preparation of a drug for treating SCN5A mutation-induced dilated cardiomyopathy (DCM) is provided. With SCN5A genotype detection as a breakthrough point, a Wnt pathway-specific inhibitor Wnt-C59 is used to inhibit the abnormal activation of the Wnt?-Catenin pathway caused by SCN5A gene mutation, thereby improving the prognosis of cardiac function in a patient with SCN5A gene mutation-induced DCM. In experiments, aging and adriamycin-induced DCM models are constructed, and the therapeutic effect of Wnt-C59 on DCM is detected through indexes such as changes in cardiac function and activation of related signal molecules, which provides a theoretical basis for use of Wnt-C59 in the clinical treatment of DCM. A new treatment method for SCN5A mutation-induced DCM is provided to bring dawn to such patients and has promising application prospects.
    Type: Application
    Filed: August 6, 2021
    Publication date: November 24, 2022
    Applicant: ZHONGSHAN HOSPITAL, FUDAN UNIVERSITY
    Inventors: Junbo GE, Aijun SUN, Jingjing HU, Kun YANG
  • Patent number: 11298802
    Abstract: The invention discloses a caliper repairing clamp, which relates to the technical field of calipers and comprises a machine body, wherein a polishing disc is arranged inside the machine body, a protective cover is arranged on the outer surface of the polishing disc, a moving table is arranged below the machine body, a polishing table is arranged above the moving table, a fixed table is fixedly connected to the upper surface of the polishing table, a first bearing is fixedly embedded inside the machine body, a rotating handle is arranged below the moving table, and a first threaded rod is fixedly connected to the upper surface of the rotating handle.
    Type: Grant
    Filed: March 12, 2020
    Date of Patent: April 12, 2022
    Assignee: CITIC Dicastal Co., Ltd.
    Inventors: Aijun Sun, Ning Ma, Liqun Zheng
  • Publication number: 20200290176
    Abstract: The invention discloses a caliper repairing clamp, which relates to the technical field of calipers and comprises a machine body, wherein a polishing disc is arranged inside the machine body, a protective cover is arranged on the outer surface of the polishing disc, a moving table is arranged below the machine body, a polishing table is arranged above the moving table, a fixed table is fixedly connected to the upper surface of the polishing table, a first bearing is fixedly embedded inside the machine body, a rotating handle is arranged below the moving table, and a first threaded rod is fixedly connected to the upper surface of the rotating handle.
    Type: Application
    Filed: March 12, 2020
    Publication date: September 17, 2020
    Inventors: Aijun Sun, Ning Ma, Liqun Zheng
  • Publication number: 20120052010
    Abstract: The present invention provides methods of using optimal PET tracers for diagnosing head and neck cancer. Non-invasive methods for assessing tumor perfusion and oxidative metabolism for in vivo imaging with PET tracers that are suitable for uses in radiation therapy (RT) in head and neck cancer and evaluation of salivary gland function are provided. A pharmaceutical comprising the PET tracer and a kit for the preparation of the pharmaceutical are provided as well.
    Type: Application
    Filed: April 29, 2010
    Publication date: March 1, 2012
    Applicant: GE HEALTHCARE LIMITED
    Inventors: Jens Sorensen, Silvia Johansson, Aijun Sun
  • Publication number: 20100258138
    Abstract: The present invention provides methods of using optimal PET tracers for diagnosing head and neck cancer. Methods for in vivo imaging uses of the PET tracers that are suitable for uses in radiation therapy (RT) in head and neck cancer and evaluation of salivary gland function are also provided. A pharmaceutical comprising the PET tracer and a kit for the preparation of the pharmaceutical are provided as well.
    Type: Application
    Filed: August 22, 2007
    Publication date: October 14, 2010
    Inventors: Jens Sorensen, Bengt Langstrom, Aijun Sun, Silvia Johansson